Search

everythinglearnresearchcommunity

for

Search:↓

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

COVID-19 may be linked to hair loss or worsening of hair loss in some people.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

TLR2 helps control hair growth and regeneration, and its reduction with age or obesity can impair hair growth.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

People with severe hair loss have lower zinc levels in their blood.

Ritlecitinib is safe and may effectively treat alopecia areata.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Hair follicle stem cells are promising for blood vessel formation and tissue repair.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.